FSD Pharma Inc. (HUGE) News

FSD Pharma Inc. (HUGE): $1.53

-0.01 (-0.65%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter HUGE News Items

HUGE News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

HUGE News Highlights

  • HUGE's 30 day story count now stands at 14.
  • Over the past 28 days, the trend for HUGE's stories per day has been choppy and unclear. It has oscillated between 1 and 6.
  • The most mentioned tickers in articles about HUGE are NEU.

Latest HUGE News From Around the Web

Below are the latest news stories about FSD Pharma Inc that investors may wish to consider to help them evaluate HUGE as an investment opportunity.

KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing

Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the presentations from the KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing.

Yahoo | October 18, 2021

FSD Pharma to Present at the KCSA Psychedelics Virtual Investor Conference on October 13th

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, is pleased to announce that Anthony Durkacz, Interim CEO of FSD Pharma, and Dr. Lakshmi P. Kotra, CEO of FSD's wholly-owned subsidiary Lucid Psycheceuticals, will participate in the KCSA Psychedelics Investor Conference to be held at VirtualInvestorConferences.com on October 13-14, 2021.

Yahoo | October 13, 2021

FSD Pharma, Developing Treatments for Mental Health Disorders

In a recent InvestorIntel interview, Tracy Weslosky spoke with Anthony Durkacz, Founder, Interim CEO and Executive Co-Chairman of FSD Pharma [] The post FSD Pharma, Developing Treatments for Mental Health Disorders appeared first on InvestorIntel .

Investor Intel | September 28, 2021

FSD Pharma Inc.: FSD Pharma Announces Engagement with Capital Markets Communications Providers and Market Maker

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced

FinanzNachrichten | September 22, 2021

InvestmentPitch.com: InvestmentPitch Media Video Discusses FSD Pharma''s Closing of its acquisition of Canadian Specialty Psychedelic Pharmaceutical Company Lucid Psycheceuticals - Video Available on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - September 22, 2021) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A), a life sciences holding company dedicated to building a portfolio of as

FinanzNachrichten | September 22, 2021

FSD Pharma Announces Engagement with Capital Markets Communications Providers and Market Maker

TORONTO, September 22, 2021--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today it has retained the services of Hybrid Financial Ltd. ("Hybrid"), North Equities Corp. (the "North Equities"), Looking Glass Capital Consultants ("Looking Glass"), Worldwide Media Solutions, LLC ("BGTV Direct"), KCSA Strategic Communications ("KCSA"), and Digi Messagin

Yahoo | September 22, 2021

InvestmentPitch Media Video Discusses FSD Pharma's Closing of its acquisition of Canadian Specialty Psychedelic Pharmaceutical Company Lucid Psycheceuticals - Video Available on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - September 22, 2021) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions in legal psychedelics and medical cannabis, has closed its acquisition of Lucid Psycheceuticals. Founded in 2020, Lucid Psycheceuticals (www.LucidPsycheceuticals.com), a Canadian-based specialty psychedelic pharmaceutical company, is developing novel molecules and combinations

Yahoo | September 22, 2021

FSD Pharma Announces Closing of Lucid Psycheceuticals Acquisition

TORONTO--(BUSINESS WIRE)---- $HUGE #RestoreFSD--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (FSD Pharma or the Company), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, is pleased to announce the completion of the previously announced acquisition of 100% of the issued and outstanding shares of Lucid Psycheceuticals Inc. (Lucid), a Canadian-based specialty psychedelic pharmaceutical company focused on the development of therapies to treat critical neu

Business Wire | September 21, 2021

Is FSD Pharma (HUGE.N) getting into psychedelics to avoid being kicked off the Nasdaq?

One billion shares No matter what FSD Pharma (HUGE.N) does, I will always remember them as the company that bragged endlessly about having more than a billion shares outstanding. That was their whole philosophy, they went so far as to go with HUGE as their ticker. They also completed the biggest reverse split I have [] The post Is FSD Pharma (HUGE.N) getting into psychedelics to avoid being kicked off the Nasdaq? appeared first on Equity.Guru .

Equity Guru | September 20, 2021

Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold

Contents California Psychedelics Bill Put On Hold Until 2022 FSD Pharma To Purchase Lucid Psycheceuticals

Business Insider Markets | August 30, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6676 seconds.